X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (60) 60
humans (54) 54
hematology (43) 43
article (34) 34
female (34) 34
male (34) 34
aged (30) 30
middle aged (28) 28
adult (25) 25
oncology (25) 25
acute myeloid-leukemia (23) 23
treatment outcome (17) 17
young adult (17) 17
myelodysplastic syndromes (16) 16
retrospective studies (16) 16
transplantation (15) 15
adolescent (14) 14
myelodysplastic syndrome (14) 14
cancer (12) 12
prognosis (12) 12
aged, 80 and over (11) 11
aplastic anemia (11) 11
bone-marrow-transplantation (11) 11
leukemia (11) 11
stem-cell transplantation (11) 11
therapy (11) 11
abridged index medicus (10) 10
bone marrow (10) 10
cyclophosphamide (10) 10
mutation (10) 10
survival rate (10) 10
azacitidine (9) 9
bone marrow failure (9) 9
care and treatment (9) 9
hemic and lymphatic diseases (9) 9
myelodysplastic syndromes - drug therapy (9) 9
myelodysplastic syndromes - mortality (9) 9
scoring system (9) 9
myelodysplastic syndromes - therapy (8) 8
stem cells (8) 8
child (7) 7
disease (7) 7
disease-free survival (7) 7
mutations (7) 7
myelodysplastic syndromes - diagnosis (7) 7
paroxysmal nocturnal hemoglobinuria (7) 7
patients (7) 7
risk (7) 7
survival (7) 7
transplantation, homologous (7) 7
disease progression (6) 6
health aspects (6) 6
hematology, oncology and palliative medicine (6) 6
hematopoietic stem cell transplantation (6) 6
hematopoietic stem cells (6) 6
immunosuppressive therapy (6) 6
myelodysplastic syndromes - pathology (6) 6
surgical procedures, operative (6) 6
versus-host-disease (6) 6
analysis (5) 5
azacitidine - analogs & derivatives (5) 5
bone marrow transplantation - adverse effects (5) 5
clinical trials (5) 5
cyclophosphamide - administration & dosage (5) 5
cyclophosphamide - therapeutic use (5) 5
diagnosis (5) 5
disorders (5) 5
graft vs host disease - prevention & control (5) 5
hematologic malignancies (5) 5
immunosuppressive agents - therapeutic use (5) 5
immunotherapy (5) 5
kaplan-meier estimate (5) 5
mds (5) 5
medical research (5) 5
myelodysplastic syndromes - genetics (5) 5
response criteria (5) 5
time factors (5) 5
transfusion-dependent patients (5) 5
acute myeloid leukemia (4) 4
anemia (4) 4
anemia, aplastic - therapy (4) 4
antibodies, monoclonal, humanized - therapeutic use (4) 4
antineoplastic agents - therapeutic use (4) 4
antithymocyte globulin (4) 4
aplastic-anemia (4) 4
blood (4) 4
bone marrow transplantation (4) 4
child, preschool (4) 4
chronic myelomonocytic leukemia (4) 4
clonal hematopoiesis (4) 4
dose-response relationship, drug (4) 4
eculizumab (4) 4
education, scientific disciplines (4) 4
evolution (4) 4
failure (4) 4
follow-up studies (4) 4
further section (4) 4
genes (4) 4
graft vs host disease - etiology (4) 4
hematopoiesis (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Hematology, ISSN 1520-4391, 11/2018, Volume 2018, Issue 1, pp. 277 - 285
Abstract The myelodysplastic syndromes are collectively the most common myeloid neoplasms. Clonal hematopoiesis present in these diseases results in bone... 
Journal Article
Hematology. American Society of Hematology. Education Program, ISSN 1520-4391, 11/2018, Volume 2018, Issue 1, pp. 277 - 285
The myelodysplastic syndromes are collectively the most common myeloid neoplasms. Clonal hematopoiesis present in these diseases results in bone marrow failure... 
PROGNOSTIC IMPACT | DRIVER SOMATIC MUTATIONS | LENALIDOMIDE | RISK | ACUTE MYELOID-LEUKEMIA | TP53 MUTATIONS | SCORING SYSTEM | SF3B1 MUTATION | TET2 FUNCTION | HEMATOLOGY | MYELODYSPLASTIC SYNDROME | EDUCATION, SCIENTIFIC DISCIPLINES
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 12/2018, Volume 24, Issue 12, pp. e26 - e30
Paroxysmal nocturnal hemoglobinuria (PNH) often develops secondary to other bone marrow failure (BMF) disorders, especially aplastic anemia (AA). Patients with... 
Eculizumab | Paroxysmal nocturnal hemoglobinuria | Aplastic anemia | Transplant | Bone marrow | Cyclophosphamide | Transplantation | Stem cells
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Suppl_1, pp. 4374 - 4374
Abstract Background: Only a minority of patients diagnosed with myelodysplastic syndromes (MDS) enroll in interventional clinical trials, which impedes... 
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 03/2018, Volume 24, Issue 3, p. S298
Journal Article
Cancer, ISSN 0008-543X, 05/2017, Volume 123, Issue 10, pp. 1689 - 1694
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 793 - 793
Abstract Background Patients (pts) with myelodysplastic syndromes (MDS) have heterogeneous outcomes that can range from months for some pts to decades for... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 3095 - 3095
Abstract Background: Previous studies suggest that survival improves when patients (pts) with rare cancers are treated at specialty centers. Majority of MDS... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 3096 - 3096
Abstract Background: For some rare cancers, better outcomes have been reported for patient (pts) treated at high volume or specialty centers compared to pts... 
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 03/2018, Volume 24, Issue 3, pp. S298 - S298
Journal Article
Cytometry Part B: Clinical Cytometry, ISSN 1552-4949, 01/2018, Volume 94, Issue 1, pp. 16 - 22
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 4370 - 4370
Abstract Background Myelodysplastic syndromes (MDS) are a collection of hematopoietic disorders with widely variable prognoses and treatment options.... 
Journal Article
Current Hematologic Malignancy Reports, ISSN 1558-8211, 06/2019, Volume 14, Issue 3, pp. 154 - 163
Journal Article
Blood, ISSN 0006-4971, 11/2012, Volume 120, Issue 21, pp. 3475 - 3475
Abstract Abstract 3475 Cytopenias in the context of cellular marrows cause significant morbidity for patients and are challenging for clinicians to diagnose... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 4322 - 4322
Abstract Introduction While lenalidomide (LEN) is the standard of care for treatment of red blood cell (RBC) transfusion-dependent (TD) lower-risk... 
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 2901 - 2901
Abstract Background: Outcomes of patients (pts) with refractory and relapsed higher-risk myelodysplastic syndromes (HR-MDS) and acute myeloid leukemia with... 
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 2031 - 2031
Abstract SAA is a life-threatening hematopoietic stem cell disorder that is treated with either bone marrow transplantation (BMT) or immunosuppressive therapy... 
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 3286 - 3286
Abstract Introduction: In clinical studies of patients (pts) with International Prognostic Scoring System (IPSS)-defined Low- to Intermediate-1-risk... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.